NCT04112459

Brief Summary

Scientific advances, population growth, lower mortality, and increasing complexity of diseases have boosted up the number of patients requiring prolonged breathing assistance with mechanical ventilators in the pediatric intensive care units (PICU) in many parts of the developed world. Previous studies also suggest that there is a small group of children who actually need such a high level of support for extended periods of time, utilizing a lot of human and technical resources. We defined children with prolonged mechanical ventilation (PMV) if they required supports with a breathing machine for more than 14 days. We propose an international point prevalence study of children requiring PMV in PICU. We will conduct the study in multiple centers in several different regions, including North and South America, Europe, and Asian countries, with a strong relationship with local physician colleagues. Practice for patients requiring PMV will be examined including the type and size of local PICU, admission and discharge policies, and patient and treatment modalities administered to such patients, types of professionals looking after patients in PMV, types of health care. We anticipate a high variability in practices suggesting a need to further standardize the management of PMV.. Specifically, as an immediate consequence, by comparing and understanding the differences in patient demographics, practice details among PICUs in regards to the background factors of local PICUs and their patients, practitioners will share their way of dealing with such patients. In that way, this study will support the need to generate guidelines and lead to patient care improvement in PICUs.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 4, 2019

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

September 27, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 2, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 4, 2022

Completed
Last Updated

October 2, 2019

Status Verified

September 1, 2019

Enrollment Period

2 years

First QC Date

September 27, 2019

Last Update Submit

September 30, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of PMV

    number of patients meet PMV criteria devided by the number of patients admitted in PICUs on the specific data collection date and time.

    eight times during two-year study period

Secondary Outcomes (2)

  • Patient and treatment demographics

    eight times during two-year study period

  • Outcomes at 90days follow-up

    90 days from the initial data collection

Interventions

No intervention will be applied in this study

Eligibility Criteria

Age37 Weeks - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All patients on invasive or non-invasive mechanical ventilation on the day of the study or patients who had been on InMV or non-invasive ventilation (NIVs) during their PICU stays will be eligible. Patients who fulfill inclusion criteria and do not meet any exclusion criteria will be considered for inclusion in the study.

You may qualify if:

  • Patients who are ventilated \>14 consecutive days (after 37 weeks postmenstrual post-conception age)\*
  • including for more than 6 hours per day including on InMV and NIV duration
  • patient who have had and short interruptions (\<48hours) of ventilation during the weaning process as the same episode of ventilation can be included.
  • InMV can be administered through an endotracheal tube or a tracheostomy tube.
  • NIV can be managed through a nasal, full-face, total facial mask, or helmet.
  • Patient on HFNC will be included as on respiratory support if they have a proper or a nasal cannula (that allows \>=1 liters/kg/min (LPM) and \>4LPM).
  • We define nasal oxygen supply \<1 L/kg/min as non-NIV practice.

You may not qualify if:

  • Age \>18 years
  • Already included in this study
  • No consent if required
  • Brain death
  • Premature children not yet at 37 weeks gestational age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Sainte Justine

Montreal, Quebec, H3T 1C5, Canada

RECRUITING

Related Publications (1)

  • Kawaguchi A, Fernandez A, Baudin F, Chiusolo F, Lee JH, Brierley J, Colleti J Jr, Reiter K, Won Kim K, Lopez Fernandez Y, Kneyber M, Pons-Odena M, Napolitano N, Graham RJ, Kawasaki T, Garros D, Garcia Guerra G, Jouvet P; LongVentKids study group. Prevalence, management, health-care burden, and 90-day outcomes of prolonged mechanical ventilation in the paediatric intensive care unit (LongVentKids): an international, prospective, cross-sectional cohort study. Lancet Child Adolesc Health. 2025 Jan;9(1):37-46. doi: 10.1016/S2352-4642(24)00296-7.

Study Officials

  • Philippe Jouvet, MD PhD MBA

    St. Justine's Hospital

    STUDY DIRECTOR

Central Study Contacts

Atsushi Kawaguchi, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postdoctoral Scholar

Study Record Dates

First Submitted

September 27, 2019

First Posted

October 2, 2019

Study Start

September 4, 2019

Primary Completion

September 3, 2021

Study Completion

September 4, 2022

Last Updated

October 2, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will share

Data sharing agreement will be mandatory to be signed between the central coordination center (CHU Sainte Justine) and the participating center.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
After all the data collection completed, summarized de-identified study result will be shared with the participating centers. Patient individual data will be shared between the central coordinating center and the center where PI of ancillary and posthoc study belongs.
Access Criteria
All the study protocol and CRF will be shared with the participating centers.

Locations